(Q35947404)

11 August 2017

1 reference

title

Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms (English)

1 reference

11 August 2017

1 reference

extrapyramidal symptoms

1 reference

Richard M Trosch

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Journal of the American Geriatrics Society

11 August 2017

published in

1 reference

11 August 2017

volume

52

1 reference

11 August 2017

issue

12 Suppl

1 reference

11 August 2017

page(s)

S266-71

1 reference

Olanzapine-induced tardive dystonia

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Acute laryngeal dystonic reactions to neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Current concepts. Neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Clozapine-associated neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Neuroleptic malignant syndrome associated with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Atypical antipsychotics in Parkinson-sensitive populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

Tardive dyskinesia associated with olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2004.52603.X

10.1111/J.1532-5415.2004.52603.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference